I love to see everyone. Aufra Araujo: Yeah, I love that. Aufra Araujo: But what are you going to do with all of the rain? Aufra Araujo: Hello. We are able to hear you, Jessica. 00:32:27 Brenda Goodman, CNN Thank you, Dr. Pillai. 00:27:30 Mr. Haynes Thank you, sir. 00:33:40 Mr. Haynes Next query, please. 00:34:30 Mr. Haynes Next question. 00:32:20 Operator Thank you; our next question comes from Brenda Goodman with CNN; your line is open; you could ask your query. Next question from Melody Schreiber from The Guardian US; go ahead your line is open. 00:35:Fifty six Operator Thanks and have questions for Sabrina Siddiqui with Wall Street Journal your line is open and reply your questions. 00:36:05 Sabrina Siddiqui, The Wall Street Journal Thanks for doing this, and I know you’ve got been deferring extra of those diplomatic questions round Kenya to the State Department so I need to ask you extra from a medical vantage point, a two-part query: One is, are you able to explain simply from a medical perspective if American patients or individuals who Americans learn how to develop it on the past have been brought again to the US to the US for remedy: Is there a reason why that this time is any different from a medical standpoint? I wanted to comply with up on the Kenya angle of this story, that Kenyan courtroom this morning temporarily blocking us from opening the quarantine center there.
00:29:31 Dr. Pillai Again, I would refer you to the Department of State because the lead company for questions pertaining to Kenya. I would refer you to the Department of State which is the lead federal company for the those efforts. I am the CDC ECHO Biosafety Program Lead and the Acting Safety Team Lead in CDC’s Division of Laboratory Systems. He has been one of the technical specialists from IFBA on ISO Technical Committee 212’s Working Group 5 Drafting Team for ISO 35001, its companion information, and a new ISO Biosafety Technical Specification. But as was mentioned beforehand, I was on the drafting crew for ISO 35001, Biorisk Management for Laboratories and Other Related Organizations. The field on this slide shows a poll question from the session and the response for where ECHO participants have been in the implementation of biorisk management at their establishment. Now, I would like to offer a quick recap from final month’s ECHO session which was in August. Here is a short overview of as we speak’s session. Today’s subject material skilled is Benjamin, or Ben, Fontes from Yale Environmental Health & Safety in New Haven, Connecticut.
Today’s name is being recorded if in case you have any objections it’s possible you’ll disconnect at the moment you’d now introduce Mr. Benjamin Haynes; thanks sir, chances are you’ll begin. You may cling up at any time. Two fast questions: One is, does this individual who’s infected have a household And the second is, back in 2023, there was an article from the Journal of Infectious Diseases about use of a recombinant vesicular stomatitis virus-based mostly vaccine to provide some post-publicity protection against the Bundibugyo. Just one quick comply with up to what you just stated: Can you quantify at all what is the CDC employees responses in terms of, you already know, helping, helping out at those 4 locations? I’ve bought staff domestically and internationally and, simply to reiterate, staff are keen to hitch this response as a result of they see CDC’s public health prior to now, completely satisfied in this work, and we have now volunteers from throughout the businesses have reached out.
Thank you. I’ve 2 questions; so the first is that can you make clear that the 6 individuals who’ve been uncovered are in transit to Germany, I just wanna make certain I understood that, and in addition there are there have been monoclonal antibodies which have been identified as being effective in non-human primates towards the pressure of Ebola, and I’m simply wondering if there are efforts now underway to create a monoclonal antibody therapy that may very well be used for that purpose? 00:38:57 Dr. Pillai Rather than enumerating the a number of differing types of the way to judge it in individual, I would refer you to our CDC clinical internet pages which does present an in depth description on how people may be and once more as a overarching point I think you will need to understand that informal exposures and and and don’t lend itself to sort of risk and that the risk to the American individuals the principle earnings very low.
Leave a Reply